arsenic has been researched along with methotrexate in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (50.00) | 18.7374 |
| 1990's | 4 (11.11) | 18.2507 |
| 2000's | 3 (8.33) | 29.6817 |
| 2010's | 11 (30.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zachariae, H | 2 |
| Briggs, WT; Horne, DW; Wagner, C | 1 |
| Bastos, MT; Campello, AP; Klüppel, ML; Oliveria, MB | 1 |
| Chang, KP; Katakura, K | 1 |
| Barrett, JC; Gilmer, TM; Lamb, PW; Lee, TC; Tanaka, N | 1 |
| Hönigsmann, H; Ortel, B; Tanew, A; Wolff, K; Zussner, C | 1 |
| Cappuccino, JG; Schmid, FA; Stock, CC; Tarnowski, GS | 1 |
| Galt, RM; Knock, FE; Oester, YT; Sylvester, R | 1 |
| Newbold, PC | 1 |
| Fossati, C | 1 |
| Bagai, RC; Harris, JE; Stewart, TH | 1 |
| Pürschel, W; Schulmeyer, M | 1 |
| Korting, GW | 1 |
| Haustein, UF; Kluge, K; Meffert, H; Sönnichsen, N | 1 |
| Denk, R; Sachsse, W | 1 |
| Bishop, CF; Melnykovych, G | 1 |
| El'kin, VD; Osnovina, NG | 1 |
| Lindelöf, B; Sigurgeirsson, B | 1 |
| Binder, M; Hönigsmann, H; Maier, H; Ortel, B; Schemper, M; Tanew, A | 1 |
| Gottesman, MM; Pastan, I; Shen, D | 1 |
| DIPAOLO, JA | 1 |
| KNOCK, FE | 1 |
| Au, WY; Fong, BM; Kwong, YL; Tam, S | 1 |
| Aguirre, V; Arriagada, S; Bertoglio, JC; Burgos, RA; Cáceres, DD; Calvo, M; Hancke, JL | 1 |
| Blinder, R; Chang, P; Galinsky, I; Ho, VT; Housman, E; Kesari, S; Lane, SW; Mullally, A; Stone, RM | 1 |
| Appelbaum, FR; Couban, S; Coutre, S; Feusner, JH; Gallagher, RE; Gregory, J; Larson, RA; Moser, B; Powell, BL; Rowe, JM; Stock, W; Stone, RM; Tallman, MS; Willman, CL | 1 |
| Gong, YP; Luo, S; Yang, L; Yang, YM | 1 |
| Anderson, LD; Collins, RH; Kirk, A; Levitt, D; Naina, HV; Scaglioni, PP; Vusirikala, M | 1 |
| Hirano, T; Onda, K; Sugiyama, K; Tanaka, S; Tohyama, N | 1 |
| Huang, J; Jin, J; Lou, Y; Mai, W; Meng, H; Qian, W; Tong, H; Tong, Y | 1 |
| Altman, JK; Appelbaum, FR; Attar, EC; Coutre, SE; Gore, SD; Kopecky, KJ; Larson, RA; Levitan, D; Maher, T; Othus, M; Paietta, E; Powell, B; Stock, W; Tallman, MS; Wetzler, M; Willman, CL | 1 |
| Iacoboni, G; Montesinos, P; Sanz, MA | 1 |
| Cole, SP; Leslie, EM; Marensi, V; Rousseau, RK; Shukalek, CB; Swanlund, DP; Weigl, KE | 1 |
| Raichaudhuri, A | 1 |
| Alonzo, TA; Feusner, JH; Fu, CH; Gamis, AS; Gerbing, RB; Gregory, JJ; Hirsch, BA; Kutny, MA; Meshinchi, S; Raimondi, SC; Wang, YC | 1 |
7 review(s) available for arsenic and methotrexate
| Article | Year |
|---|---|
[Internal treatment of psoriasis--a review].
Topics: Arsenic; DNA; Ficusin; Glucocorticoids; Humans; Methotrexate; Psoriasis; Ultraviolet Therapy | 1976 |
Antimetabolites and psoriasis.
Topics: Adrenal Cortex Hormones; Animals; Antimetabolites; Arsenic; Humans; Hydroxyurea; Methotrexate; Mice; Neoplasms; Nucleic Acids; Protein Biosynthesis; Psoriasis; Time Factors; Ultraviolet Rays | 1972 |
[Liver damage due to drugs. I].
Topics: Arsenicals; Chemical and Drug Induced Liver Injury; Chloramphenicol; Cholestasis; Coumarins; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Halothane; Humans; Imipramine; Liver; Methotrexate; Methyldopa; Nicotinic Acids; Oxacillin; Phenylbutazone; Testosterone; Tetracycline | 1974 |
[Psoriasis vulgaris. Internal therapy].
Topics: Arsenic; Bromine; Cortisone; Folic Acid Antagonists; Humans; Indomethacin; Methotrexate; Psoriasis; Vitamin D | 1966 |
[Current knowledge on the pathogenesis of common psoriasis as the basis for a scientifically founded therapy. II. Therapeutic possibilities and pathogenetic principles of antipsoriatic drugs].
Topics: Anthracenes; Arsenic; Baths; Glucocorticoids; Humans; Mercury; Methotrexate; Psoriasis; Salicylates; Tars; Ultraviolet Therapy | 1970 |
NEWER ANTICANCER AGENTS.
Topics: Alkylating Agents; Antineoplastic Agents; Arsenicals; Cyclophosphamide; Dactinomycin; Fluorouracil; Humans; Mechlorethamine; Melphalan; Methotrexate; Mitomycin; Mitomycins; Neoplasms; Pharmacology; Steroids; Triethylenemelamine; Vinblastine; Vincristine | 1964 |
Conventional induction and post-remission therapy in APL: have we arrived?
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Clinical Trials as Topic; Consolidation Chemotherapy; Daunorubicin; Harringtonines; Homoharringtonine; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Mitoxantrone; Multicenter Studies as Topic; Oxides; Remission Induction; Tretinoin | 2014 |
4 trial(s) available for arsenic and methotrexate
| Article | Year |
|---|---|
Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Andrographis; Arsenicals; Arthralgia; Arthritis, Rheumatoid; Chloroquine; Double-Blind Method; Drug Therapy, Combination; Female; Glutathione; Humans; Methotrexate; Middle Aged; Phytotherapy; Placebos; Plant Extracts; Plant Leaves; Prednisone; Prospective Studies; Radiography; Severity of Illness Index; Young Adult | 2009 |
Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Middle Aged; North America; Oxides; Survival Analysis; Treatment Outcome; Tretinoin; Young Adult | 2010 |
Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy.
Topics: Adult; Aged; Aminoglycosides; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Disease-Free Survival; Dogs; Female; Gemtuzumab; Humans; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Male; Mercaptopurine; Methotrexate; Middle Aged; Oncogene Proteins, Fusion; Oxides; Platelet Count; Remission Induction; Risk; Treatment Outcome; Tretinoin; Young Adult | 2014 |
Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631.
Topics: Adolescent; Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Child; Child, Preschool; Consolidation Chemotherapy; Cytarabine; Disease-Free Survival; Female; Historically Controlled Study; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Oxides; Young Adult | 2017 |
25 other study(ies) available for arsenic and methotrexate
| Article | Year |
|---|---|
A functional, active transport system for methotrexate in freshly isolated hepatocytes.
Topics: Animals; Arsenic; Biological Transport, Active; Dinitrophenols; Folic Acid; In Vitro Techniques; Iodoacetamide; Kinetics; Leucovorin; Liver; Male; Methotrexate; Ouabain; Perfusion; Rats | 1976 |
Methotrexate: studies on cellular metabolism. IV. Effect on the mitochondrial oxidation of cytosolic-reducing equivalents in HeLa cells.
Topics: Arsenic; Arsenites; Aspartate Aminotransferases; Aspartic Acid; Cytosol; HeLa Cells; Humans; Malate Dehydrogenase; Malates; Methotrexate; Mitochondria; Oxidation-Reduction | 1990 |
H DNA amplification in Leishmania resistant to both arsenite and methotrexate.
Topics: Animals; Arsenic; Arsenites; Blotting, Southern; DNA Probes; DNA, Circular; DNA, Superhelical; Drug Resistance; Electrophoresis; Gene Amplification; Genetic Variation; Leishmania; Methotrexate; Multienzyme Complexes; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase | 1989 |
Induction of gene amplification by arsenic.
Topics: Animals; Arsenates; Arsenic; Arsenites; Cell Line; DNA; Drug Resistance; Gene Amplification; Humans; Methotrexate; Mice; Neoplasms, Experimental; Nucleic Acid Hybridization; Oncogenes; Sodium Compounds; Tetrahydrofolate Dehydrogenase | 1988 |
Nonmelanoma skin tumors in long-term photochemotherapy treatment of psoriasis. An 8-year follow-up study.
Topics: Adult; Aged; Aging; Arsenic; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Dose-Response Relationship, Radiation; Etretinate; Follow-Up Studies; Humans; Melanoma; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Skin Neoplasms | 1986 |
Chemotherapy studies in an animal tumor spectrum. II. Sensitivity of tumors to fourteen antitumor chemicals.
Topics: Animals; Antineoplastic Agents; Arsenicals; Busulfan; Cyclophosphamide; Dactinomycin; Diethylstilbestrol; Floxuridine; Fluorouracil; Hydrocortisone; Mercaptopurine; Methotrexate; Mice; Mitomycins; Neoplasms, Experimental; Urethane; Vinblastine | 1966 |
In vitro estimate of sensitivity of individual human tumors to antitumor agents.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Arsenicals; Benzoates; Breast Neoplasms; Carbon Radioisotopes; Carcinoma; Carcinoma, Ehrlich Tumor; Cattle; Depression, Chemical; DNA, Neoplasm; Female; Fluorouracil; Humans; In Vitro Techniques; Iodoacetates; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Mice; Neoplasms; Phenylalanine; Succinate Dehydrogenase; Thymidine; Tritium | 1974 |
Use of plasma-free medium for the in vitro culture of human lymphocytes.
Topics: Adult; Aged; Arsenicals; Cells, Cultured; Culture Media; Female; Humans; Hydrocortisone; Immunity, Cellular; Insulin; Lectins; Lymphocyte Activation; Lymphocytes; Male; Methotrexate; Methylcellulose; Neoplasms; Penicillins; Plasma; Streptomycin; Thymidine; Tritium | 1973 |
[Psoriasis vulgaris--catamnesis and climate therapy of the North Sea].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Arsenic; Bathing Beaches; Climate; Climatotherapy; Evaluation Studies as Topic; Female; Germany, East; Health Resorts; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Seawater; State Medicine; Sunlight | 1973 |
[Chromosome investigations in lymphocytes and bone marrow from long term methotrexate-treated psoriatics].
Topics: Adult; Aged; Arsenicals; Bone Marrow; Bone Marrow Cells; Chromosomes; Humans; Lymphocytes; Male; Methotrexate; Middle Aged; Mutation; Psoriasis | 1970 |
Specific binding of cortisol in subcellular fractions of HeLa cells: temperature dependence and effects of inhibitors.
Topics: 17-Hydroxycorticosteroids; Arsenicals; Azides; Binding Sites; Cell Nucleus; Chloramphenicol; Cyanides; Cycloheximide; Cytoplasm; Dactinomycin; Depression, Chemical; Dinitrophenols; Female; Fluorouracil; HeLa Cells; Hexoses; Humans; Hydrocortisone; In Vitro Techniques; Iodoacetates; Methotrexate; Microsomes; Mitochondria; Ouabain; Prednisolone; Puromycin; Temperature; Tritium | 1971 |
[Multiple superficial skin basalioma in a patient with psoriasis].
Topics: Arsenic; Carcinoma, Basal Cell; Drug Therapy, Combination; Humans; Male; Methotrexate; Neoplasms, Multiple Primary; Psoriasis; Skin Neoplasms | 1980 |
PUVA and cancer: a case-control study.
Topics: Adult; Aged; Arsenic; Carcinoma, Squamous Cell; Case-Control Studies; Coal Tar; Combined Modality Therapy; Female; Humans; Hydroxyurea; Male; Methotrexate; Middle Aged; PUVA Therapy; Radiotherapy; Skin Neoplasms; Ultraviolet Therapy; X-Rays | 1993 |
Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Arsenic; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Child; Cocarcinogenesis; Dermatologic Agents; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Radiation Dosage; Regression Analysis; Retinoids; Retrospective Studies; Risk Factors; Skin Neoplasms; Tars; Ultraviolet Rays; X-Rays | 1996 |
Cross-resistance to methotrexate and metals in human cisplatin-resistant cell lines results from a pleiotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins.
Topics: Antineoplastic Agents; Arsenicals; Blotting, Northern; Carcinoma, Squamous Cell; Carrier Proteins; Cell Membrane; Cisplatin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorescent Antibody Technique, Indirect; Folate Receptors, GPI-Anchored; Humans; Liver Neoplasms; Membrane Proteins; Metals; Methotrexate; Neoplasm Proteins; Receptors, Cell Surface; Tumor Cells, Cultured | 1998 |
IN VITRO TEST SYSTEMS FOR CANCER CHEMOTHERAPY. II. CORRELATION OF IN VITRO INHIBITION OF DEHYDROGENASE AND GROWTH WITH IN VIVO INHIBITION OF EHRLICH ASCITES TUMOR.
Topics: Animals; Antineoplastic Agents; Arsenicals; Carbamates; Carcinoma; Carcinoma, Ehrlich Tumor; Colchicine; Dactinomycin; Diethylstilbestrol; Enzyme Inhibitors; Fluorouracil; Hydrocortisone; In Vitro Techniques; Mechlorethamine; Mercaptopurine; Methotrexate; Mice; Oxidoreductases; Research; Thalidomide; Thiotepa | 1963 |
Have methotrexate-induced liver fibrosis and cirrhosis become rare? A matter for reappraisal of routine liver biopsies.
Topics: Alcohol Drinking; Arsenicals; Biomarkers; Biopsy; Dermatologic Agents; Humans; Liver; Liver Cirrhosis; Methotrexate; Peptide Fragments; Procollagen; Psoriasis; Vitamin A | 2005 |
Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Arsenic; Arsenic Trioxide; Arsenicals; Cytarabine; Female; Humans; Injections, Spinal; Leukemia, Promyelocytic, Acute; Male; Methotrexate; Middle Aged; Oxides; Recurrence | 2008 |
CNS relapse in acute promyeloctyic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Marrow Neoplasms; Brain Neoplasms; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cranial Irradiation; Cytarabine; Drug Administration Schedule; Female; fms-Like Tyrosine Kinase 3; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Magnetic Resonance Imaging; Mercaptopurine; Methotrexate; Mutation; Nuclear Proteins; Oxides; Promyelocytic Leukemia Protein; Receptors, Retinoic Acid; Recurrence; Remission Induction; Retinoic Acid Receptor alpha; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; Translocation, Genetic; Transplantation, Autologous; Treatment Outcome; Tretinoin; Tumor Suppressor Proteins | 2010 |
[A successful case of tanshinone II A treatment for relapsed acute promyelocytic leukemia after maintainance therapy of all-trans retinoic acid and arsenic trioxide].
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Oxides; Tretinoin; Young Adult | 2010 |
Successful treatment of relapsed and refractory extramedullary acute promyelocytic leukemia with tamibarotene.
Topics: Adult; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Benzoates; Bone Marrow; Bone Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Resistance, Neoplasm; Gemtuzumab; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Leukemic Infiltration; Male; Mercaptopurine; Methotrexate; Oxides; Radionuclide Imaging; Remission Induction; Salvage Therapy; Sarcoma, Myeloid; Soft Tissue Neoplasms; Tetrahydronaphthalenes; Tretinoin | 2011 |
Influence of anticancer agents on cell survival, proliferation, and CD4+CD25+Foxp3+ regulatory T cell-frequency in human peripheral-blood mononuclear cells activated by T cell-mitogen.
Topics: Adolescent; Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Proliferation; Cell Survival; Concanavalin A; Cytokines; Dacarbazine; Female; Fluorouracil; Humans; Immunosuppressive Agents; Leukocytes, Mononuclear; Male; Methotrexate; Mitogens; Oxides; T-Lymphocytes, Regulatory; Young Adult | 2013 |
Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; China; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Dexamethasone; Drug Evaluation; Female; Harringtonines; Homoharringtonine; Humans; Idarubicin; Infusions, Intravenous; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Oncogene Proteins, Fusion; Oxides; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Tretinoin; Young Adult | 2014 |
Arsenic Triglutathione [As(GS)3] Transport by Multidrug Resistance Protein 1 (MRP1/ABCC1) Is Selectively Modified by Phosphorylation of Tyr920/Ser921 and Glycosylation of Asn19/Asn23.
Topics: Amino Acids; Animals; Antibodies, Monoclonal; Arsenic; Biological Transport; Enzyme Inhibitors; Estradiol; Glucuronates; Glycosylation; HEK293 Cells; HeLa Cells; Humans; Kinetics; Methotrexate; Molecular Weight; Multidrug Resistance-Associated Proteins; Mutant Proteins; Phosphorylation; Rabbits; Trypsin | 2016 |
Arabidopsis thaliana MRP1 (AtABCC1) nucleotide binding domain contributes to arsenic stress tolerance with serine triad phosphorylation.
Topics: Arabidopsis; Arabidopsis Proteins; Arsenic; Arsenites; ATP-Binding Cassette Transporters; Binding Sites; Casein Kinase II; Folic Acid Antagonists; Methotrexate; Phosphorylation; Protein Domains; Serine; Stress, Physiological; Vacuoles | 2016 |